Zusammenfassung
Die simultane Pankreas- und Nierentransplantation (SPK) ist eine mögliche Therapieoption für Menschen mit Diabetes mellitus Typ 1 und präterminaler Niereninsuffizienz. Trotz der Entwicklungen in den Operationstechniken und der Nachsorge wird sie bei ausreichendem Organangebot immer weniger durchgeführt, obwohl ihre Überlegenheit auch gegenüber der Lebendnierenspende wissenschaftlich gut belegt ist. Die guten Ergebnisse, die kurzen Wartezeiten und die Möglichkeit der Aufnahme in die Warteliste vor Eintritt der Dialysepflichtigkeit sollten bei den Aufklärungsgesprächen mit den Erkrankten immer berücksichtigt werden.
Abstract
Although simultaneous pancreas–kidney transplantation (SPK) is an effective treatment option for patients with type 1 diabetes mellitus and advanced chronic kidney disease, it is not offered and conducted as widely as would have been expected. At least in Europe, the numbers are stagnating or continuously decreasing. This is the case despite the excellent long-term outcome—even compared to living kidney donation—and the lack of organ shortage. The favorable results, the short waiting list time, and the feasibility of pre-emptive listing should encourage physicians to offer this treatment modality to patients with type 1 diabetes mellitus.
Literatur
System USRD (2020) USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
Lentine KL, Smith JM, Hart A et al (2022) OPTN/SRTR 2020 annual data report: Kidney. Am J Transplant 22(Suppl 2):21–136
de Boer IH, Sun W, Cleary PA et al (2011) Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 365:2366–2376
Nathan DM, Cleary PA, Backlund JY et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653
Fioretto P, Steffes MW, Sutherland DE et al (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69–75
Giannarelli R, Coppelli A, Sartini M et al (2005) Effects of pancreas-kidney transplantation on diabetic retinopathy. Transpl Int 18:619–622
Allen RD, Al-Harbi IS, Morris JG et al (1997) Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation 63:830–838
Nankivell BJ, al-Harbi IS, Morris J et al (1997) Recovery of diabetic neuropathy after pancreas transplantation. Transplant Proc 29:658–659
Hathaway DK, Abell T, Cardoso S et al (1994) Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life. Transplantation 57:816–822
Jukema JW, Smets YF, van der Pijl JW et al (2002) Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 25:906–911
Khairoun M, de Koning EJ, van den Berg BM et al (2013) Microvascular damage in type 1 diabetic patients is reversed in the first year after simultaneous pancreas-kidney transplantation. Am J Transplant 13:1272–1281
Lombardo C, Perrone VG, Amorese G et al (2000) Update on pancreatic transplantation in the management of diabetes. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Hershman JM, Hofland J, Kalra S, Kaltsas G, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Morley JE, New M, Purnell J, Sahay R, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP (Hrsg) Endotext. MDText.com, South Dartmouth, S 2000–2022
Sharda B, Jay CL, Gurung K et al (2022) Improved surgical outcomes following simultaneous pancreas-kidney transplantation in the contemporary era. Clin Transplant 36(11):e14792
Schreiber PW, Laager M, Boggian K et al (2022) Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study. J Hosp Infect 128:47–53
Cerise A, Shaker T, LeNguyen P et al (2022) Recipient and graft outcomes in simultaneous kidney and pancreas transplantation with steroid avoidance in the United States. Transplantation. https://doi.org/10.1097/TP.0000000000004295
Ji M, Wang M, Hu W et al (2022) Survival after simultaneous pancreas-kidney transplantation in type 1 diabetes: The critical role of early pancreas allograft function. Transpl Int 35:10618
Lindahl JP, Hartmann A, Horneland R et al (2013) Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease. Diabetologia 56:1364–1371
Montagud-Marrahi E, Cuadrado-Payán E, Hermida E, et al (2022) Preemptive simultaneous pancreas kidney transplantation has survival benefit to patients. Kidney Int 102:421–430
v Bruchem M (2022) Chapter 7, ET pancreas allocation. In: Eutotransplant manual version 2022 (Version 2022.1)
(2021) Report EA. https://www.eurotransplant.org/statistics/annual-report/. Zugegriffen: 20.11.2022
al KPe (2020) OPTN/SRTR 2020 annual data report: Pancreas
Jahresbericht DSO (2021) Pankeastransplantationen (inkl Kombinationen)
Rosenstock J, Bajaj HS, Janež A et al (2020) Once-weekly insulin for type 2 diabetes without previous insulin treatment. N Engl J Med 383:2107–2116
Marso SP, McGuire DK, Zinman B et al (2017) Efficacy and safety of degludec versus glargine in type 2 diabetes. N Engl J Med 377:723–732
Li H, Yang A, Zhao S et al (2022) Continuous subcutaneous insulin infusion (CSII) combined with oral glucose-lowering drugs in type 2 diabetes: A systematic review and network meta-analysis of randomized, controlled trials. Pharmaceuticals (Basel) 15(8):953
Renard E (2022) Automated insulin delivery systems: From early research to routine care of type 1 diabetes. Acta Diabetol. https://doi.org/10.1007/s00592-022-01929-5
Russell SJ, Beck RW, Damiano ER et al (2022) Multicenter, randomized trial of a bionic pancreas in type 1 diabetes. N Engl J Med 387:1161–1172
Wullstein C, Woeste G, Taheri AS et al (2003) Morbidity following simultaneous pancreas/kidney transplantation. Chirurg 74:652–656
Xue W, Huang Z, Zhang Y et al (2022) Patient, kidney, and pancreas survival in pancreas after kidney transplantation versus simultaneous pancreas and kidney transplantation: meta-analysis. BJS Open. https://doi.org/10.1093/bjsopen/zrac108
Niederhaus SV (2015) Pancreas transplant alone. Curr Opin Organ Transplant 20:115–120
Shapiro AM, Pokrywczynska M, Ricordi C (2017) Clinical pancreatic islet transplantation. Nat Rev Endocrinol 13:268–277
Singh N, Parsons R, Lentine KL et al (2021) Simultaneous pancreas-kidney transplantation for type 2 diabetes mellitus. Transplantation 105:e91–e92
Srinivas TR, Shoskes DA (2010) Kidney and Pancreas Transplantation: A Practical Guide. Humana Press
Vinkers MT, Rahmel AO, Slot MC et al (2008) How to recognize a suitable pancreas donor: a Eurotransplant study of preprocurement factors. Transplant Proc 40:1275–1278
Axelrod DA, Sung RS, Meyer KH et al (2010) Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization. Am J Transplant 10:837–845
Ayami MS, Grzella S, Kykalos S et al (2018) Pancreas donor risk index but not pre-procurement pancreas allocation suitability score predicts pancreas graft survival: A cohort study from a large German pancreas transplantation center. Ann Transplant 23:434–441
Sucher R, Schiemanck T, Hau HM et al (2022) Influence of intraoperative hemodynamic parameters on outcome in simultaneous pancreas-kidney transplant recipients. J Clin Med 11(7):1966
Jahn N, Völker MT, Laudi S et al (2022) Analysis of volatile anesthetic-induced organ protection in simultaneous pancreas-kidney transplantation. J Clin Med 11(12):3385
Jahn N, Voelker MT, Laudi S et al (2022) Correlation of different serum biomarkers with prediction of early pancreatic graft dysfunction following simultaneous pancreas and kidney transplantation. J Clin Med 11(9):2563
Lin L, Chen Z, Liu L et al (2022) Comparison of color Doppler ultrasonography and computed tomography angiography (CTA) and computed tomography venography (CTV) in the diagnosis of arteriovenous thrombosis after simultaneous pancreas-kidney transplantation: a retrospective diagnostic accuracy study. Ann Transl Med 10:770
Niederhaus SV, Leverson GE, Lorentzen DF et al (2013) Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes. Am J Transplant 13:2945–2955
Williams MD, Fei M, Schadde E et al (2022) Early experience using donor-derived cell-free DNA for surveillance of rejection following simultaneous pancreas and kidney transplantation. Transplant Direct 8:e1321
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Chatzikyrkou gibt an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Chatzikyrkou, C. Transplantationsmöglichkeiten für Patienten mit Diabetes und fortgeschrittener Niereninsuffizienz. Diabetologie 19, 281–287 (2023). https://doi.org/10.1007/s11428-022-00995-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-022-00995-1
Schlüsselwörter
- Pankreas-Nieren-Transplantation
- Diabetes mellitus Typ 1
- Warteliste
- Intraoperative Komplikationen
- Immunsuppression